Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
CAMBRIDGE, Mass., April 02, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease,...
-
SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced...
-
NEEDHAM, Mass., April 02, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal...
-
BOSTON, April 02, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company,...
-
HOUSTON, April 02, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (NASDAQ: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with...
-
Transaction in Own Shares 02 April 2026 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 02 April 2026 it purchased the following number of Shares for...
-
Ilkka Oyj Stock Exchange Release 2 April 2026, at 07:00 p.m. EESTIlkka Oyj: Acquisition of own shares on 2 April 2026 Date2 April 2026 Exchange transactionBuy Share...
-
Ilkka Oyj Pörssitiedote 2.4.2026, klo 19:00 Ilkka Oyj:n omien osakkeiden hankinta 2.4.2026 Päivämäärä2.4.2026 PörssikauppaOsto OsakelajiILKKA2 Osakemäärä (kpl)1...
-
La déclaration des transactions sur actions propres réalisées le 1er avril 2026 est disponible ici sur www.scor.com. Pièce jointe 202604_SCOR_Déclaration art 5.5 MAR 5...
-
DALLAS, April 02, 2026 (GLOBE NEWSWIRE) -- CSW Industrials, Inc. (NYSE: CSW) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.30 per share,...